Month: March 2022

Ventyx Biosciences Reports Full Year 2021 Financial Results and Highlights Recent Corporate Progress

Written by Customer Service on March 23, 2022. Posted in Earnings Releases And Operating Results.

Topline Phase 1 data for our allosteric TYK2 inhibitor, VTX958, expected in early Q3 2022 Topline Phase 1 data for our oral, selective NLRP3 inhibitor, VTX2735, expected in Q2 2022 Phase 2 trial of our S1P1R modulator, VTX002, continues to enroll in ulcerative colitis (UC) Strong cash position with year-end cash, cash equivalents and marketable securities of $286.7M ENCINITAS, Calif., March 23, 2022 (GLOBE NEWSWIRE) — Ventyx Biosciences, Inc. (Nasdaq: VTYX), (“Ventyx”), a clinical-stage biopharmaceutical company focused on advancing novel oral therapies that address a range of inflammatory diseases with significant unmet medical need, today announced financial results for the full year ended December 31, 2021 and highlighted recent pipeline and business progress. “I am proud of our team’s tremendous progress during 2021, including...

Huazhu Group Limited Reports Fourth Quarter and Full Year 2021 Unaudited Financial Results

Written by Customer Service on March 23, 2022. Posted in Earnings Releases And Operating Results.

A total of 7,830 hotels or 753,216 hotel rooms in operation as of December 31, 2021. Hotel turnover1 increased 8.3% year-over-year to RMB11.9 billion for the fourth quarter of 2021, and increased 36.4% year-over-year to RMB45.4 billion for the full year of 2021. Excluding Steigenberger Hotels AG and its subsidiaries (“DH”, or “Legacy-DH”), hotel turnover increased 2.2% year-over-year for the fourth quarter and increased 38.3% year-over-year for the full year of 2021. Revenue increased 9.1% year-over-year to RMB3.4 billion (US$526 million)2 for the fourth quarter of 2021, in line with revenue guidance previously announced of 6% to 10% compared to the fourth quarter of 2020, and increased 25.4% year-over-year to RMB12.8 billion (US$2.0 billion) for the full year of 2021. Revenue from Legacy-Huazhu segment for the fourth quarter of 2021...

Form 8.3 – [CareTech Holdings plc – 22 03 2022] – (HHL)

Written by Customer Service on March 23, 2022. Posted in Mergers And Acquisitions.

FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION(a) Full name of discloser: HARGREAVE HALE LIMITED (for Discretionary Clients)(b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. N/A(c) Name of offeror/offeree in relation to whose relevant securities this form relates: Use a separate form for each offeror/offeree CARETECH HOLDINGS PLC(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree: N/A(e) Date position held/dealing...

Net Asset Value, Dividend Declaration and Fundraising Update

Written by Customer Service on March 23, 2022. Posted in Public Companies.

23 March 2022 Octopus Apollo VCT plc Net asset value, dividend declaration and fundraising update The Board of Octopus Apollo VCT plc (the “Company”) announces that as at 31 January 2022 the unaudited Net Asset Value (“NAV”) of the Company was 50.2 pence per share. The Board has today declared a further interim dividend of 1.3p per share for the period ended 31 January 2022. The record date for the dividend is 22 April 2022 and the payment date is 31 May 2022. It is not anticipated that any further dividends will be declared in respect of this period. The Company announced on 30 September 2021 that it had published a prospectus (the “Prospectus”) in connection with proposals to raise up to £75,000,000 (including an over-allotment facility), by way of an offer for subscription (the “Offer”) of new ordinary...

One Step Vending Corp. (KOSK), Executes its Second Vertical Farm Order after Acquiring 51% of Light Leaf Farms, Corp., Further Increasing 2022’s Forecasted Revenue

Written by Customer Service on March 23, 2022. Posted in Public Companies.

Harrison, NY., March 23, 2022 (GLOBE NEWSWIRE) — One Step Vending Corp. (OTC: KOSK) (“KOSK” or “the Company”), a company specializing in emerging industries acquisitions with an emphasis in marketing and distributing produce, as well as the self-serve vending market, executes its second vertical farm order after acquiring 51% of Light Leaf Farms, Corp. (“LLF”), increasing its current anticipated revenue for 2022. After the Company’s first vertical farm order, a modular farm through its strategic partner E-Roots Manufacturing, Inc. with anticipated delivery within the month of April and a summer 2022 harvest, the Company executed a second vertical farm shortly after acquiring 51% of LLF through a joint venture. The joint venture is agreed to have LLF operate the day-to-day operations on the jointly-purchased vertical farms while...

Parsons to Support NSA Cyber Exercise for Next Generation of Cyber Warriors

Written by Customer Service on March 23, 2022. Posted in Public Companies.

CENTREVILLE, Va., March 23, 2022 (GLOBE NEWSWIRE) — Parsons Corporation (NYSE: PSN) will provide support to the National Security Agency’s (NSA) three-day cyber competition – NSA Cyber Exercise (NCX) – designed to enhance the full-spectrum cyber operational capabilities of U.S. Service Academies, senior military colleges, and current employees in NSA development programs. The program will enhance participants’ cybersecurity skills, teamwork, planning, communication, critical thinking, and decision-making. The challenge will occur virtually from March 31 to April 2, 2022. NCX provide complex scenarios that ensure agility against the backdrop of an ever-evolving cyber landscape. The three-day competition requires students to evaluate and complete unclassified cyber operation scenarios in real-time, raising awareness of cyber issues...

VectivBio Presents Preclinical Data Supporting Apraglutide for Treatment of Acute Graft-Versus-Host Disease at the 48th Annual Meeting of the European Society for Blood and Marrow Transplantation

Written by Customer Service on March 23, 2022. Posted in Public Companies.

— Apraglutide, a next-generation GLP-2 analog, protected against chemotherapy-induced gastrointestinal (GI) damage and improved survival in mouse models of GI acute graft-versus-host disease (aGVHD) — — Data support regenerative, non-immunosuppressive hypothesis for clinical evaluation; launched Phase 2 STARGAZE clinical study of apraglutide in steroid-refractory GI aGVHD following FDA clearance of the company’s Investigational New Drug (IND) application — BASEL, Switzerland, March 23, 2022 (GLOBE NEWSWIRE) — VectivBio Holding AG (“VectivBio”) (Nasdaq: VECT), a clinical-stage biopharmaceutical company pioneering novel transformational treatments for severe rare conditions, today announced new preclinical data supporting the potential of apraglutide, a next-generation, long-acting GLP-2 analog, as a novel...

Brookfield Reinsurance Completes Annual Filings

Written by Customer Service on March 23, 2022. Posted in Public Companies.

BROOKFIELD, NEWS, March 23, 2022 (GLOBE NEWSWIRE) — Brookfield Reinsurance (NYSE, TSX: BAMR) announced today the filing of its 2021 annual report, including audited financial statements for the year ended December 31, 2021, on Form 20-F with the SEC on EDGAR as well as with Canadian securities regulatory authorities on SEDAR. These documents are available at bamr.brookfield.com, on SEC’s website at www.sec.gov and on SEDAR’s website at www.sedar.com. Hard copies will be provided to shareholders free of charge upon request. About Brookfield Reinsurance Brookfield Asset Management Reinsurance Partners Ltd. (NYSE: BAMR; TSX: BAMR) operates a leading reinsurance business focused on providing capital-based and annuity solutions for insurance and reinsurance companies, and pension risk transfer products for pension plan sponsors. Each...

The Joint Corp. Acquires Northeast Regional Developer Territory

Written by Customer Service on March 23, 2022. Posted in Public Companies.

– Expands Corporate Clinic Opportunity in the Northeast Region – SCOTTSDALE, Ariz., March 23, 2022 (GLOBE NEWSWIRE) — The Joint Corp. (NASDAQ: JYNT), the nation’s largest provider of chiropractic care through The Joint Chiropractic® network, acquired the regional developer territory of Northern New Jersey, representing four franchised clinics and the opportunity for additional corporate clinics, for $250,000 on March 17, 2022. “Focused on increasing our corporate clinic presence in the Northeast, The Joint acquired the regional developer territory in Northern New Jersey,” said Peter D. Holt, President and Chief Executive Officer of The Joint Corp. “This purchase expands our platform to accelerate growth as we execute our long-standing strategy to open greenfield clinics within clusters. We continue to broaden...

KANZHUN LIMITED Announces Fourth Quarter and Full Year 2021 Financial Results

Written by Customer Service on March 23, 2022. Posted in Earnings Releases And Operating Results.

BEIJING, March 23, 2022 (GLOBE NEWSWIRE) — KANZHUN LIMITED (“BOSS Zhipin” or the “Company”) (Nasdaq: BZ), a leading online recruitment platform in China, today announced its unaudited financial results for the fourth quarter and full year ended December 31, 2021. Fourth Quarter and Full Year 2021 HighlightsRevenues for the fourth quarter of 2021 were RMB1,090.7 million (US$171.1 million), an increase of 69.1% from RMB645.1 million for the same quarter of 2020. Revenues for the full year of 2021 were RMB4,259.1 million (US$668.4 million), an increase of 119.0% from RMB1,944.4 million for the full year of 2020. Calculated cash billings1 for the fourth quarter of 2021 were RMB1,169.5 million (US$183.5 million), an increase of 24.4% from RMB940.1 million for the same quarter of 2020. Calculated cash billings for the full year of...

Month: March 2022

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals